Late-onset neutropenia (LON) recur in a MS patient after the second cycle of ocrelizumab: a case report.
Giorgia Teresa ManiscalcoLia AllegoricoMaria Elena Di BattistaMario AnnunziataSimona SalvatoreValentino ManzoPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)